Lower CYP2C9 activity in Turkish patients with Beh double dagger et's disease compared to healthy subjects: a down-regulation due to inflammation?


Creative Commons License

Goktas M. T. , Hatta F., Karaca O., Kalkisim S., KILIÇ L., AKDOĞAN A., ...More

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, vol.71, no.10, pp.1223-1228, 2015 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 71 Issue: 10
  • Publication Date: 2015
  • Doi Number: 10.1007/s00228-015-1899-7
  • Title of Journal : EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • Page Numbers: pp.1223-1228

Abstract

Background We previously reported on a Swedish patient with Beh double dagger et's disease (BD) who was an ultra-rapid metaboliser of drugs catalysed by CYP2C9. Was this extreme metabolism caused by the disease?